• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酪氨酸磷酸酶受体 δ 多态性与透明细胞肾细胞癌的风险相关。

Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.

机构信息

Department of Epidemiology, Second Military Medical University, Shanghai, China.

出版信息

Gene. 2013 Jan 1;512(1):64-9. doi: 10.1016/j.gene.2012.09.094. Epub 2012 Oct 13.

DOI:10.1016/j.gene.2012.09.094
PMID:23069849
Abstract

Clear cell renal cell carcinoma (ccRCC) is a common urological malignancy. Our previous study has indicated that the protein tyrosine phosphatase receptor type delta (PTPRD) gene may play a role. To determine the effect of PTPRD genetic polymorphisms on ccRCC occurrence and progression, a total of 377 ccRCC cases and 754 matched controls were enrolled in the study. DNA sequencing and genotyping, and immunohistochemistry were conducted to test the associations of genotypes with ccRCC risk and PTPRD expression level in somatic tissues. The C allele of PTPRD rs2279776 was associated with a higher risk of ccRCC (per allele OR=1.23, P=0.03). Patients without distant metastasis at the time of surgery were followed for a median of 33.1months. Overall survival was not different between different rs2279776 genotype groups (P=0.30). The C allele was associated with a higher percentage of negative immunostaining in adjacent normal renal tissues (P=0.02). PTPRD rs2279776 SNP may be a novel genetic risk factor of ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是一种常见的泌尿系统恶性肿瘤。我们之前的研究表明,蛋白酪氨酸磷酸酶受体型δ(PTPRD)基因可能发挥作用。为了确定 PTPRD 基因多态性对 ccRCC 发生和进展的影响,共纳入 377 例 ccRCC 病例和 754 例匹配对照。进行 DNA 测序和基因分型以及免疫组织化学检测,以检测基因型与 ccRCC 风险和体细胞组织中 PTPRD 表达水平的相关性。PTPRD rs2279776 的 C 等位基因与 ccRCC 风险增加相关(每等位基因 OR=1.23,P=0.03)。手术时无远处转移的患者中位随访 33.1 个月。不同 rs2279776 基因型组之间的总生存率无差异(P=0.30)。C 等位基因与相邻正常肾组织中阴性免疫染色的百分比较高相关(P=0.02)。PTPRD rs2279776 SNP 可能是 ccRCC 的一个新的遗传风险因素。

相似文献

1
Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.蛋白酪氨酸磷酸酶受体 δ 多态性与透明细胞肾细胞癌的风险相关。
Gene. 2013 Jan 1;512(1):64-9. doi: 10.1016/j.gene.2012.09.094. Epub 2012 Oct 13.
2
D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta.D9S168 微卫星改变预示着透明细胞肾细胞癌患者预后不良,与蛋白酪氨酸磷酸酶受体 δ 的下调相关。
Cancer. 2011 Sep 15;117(18):4201-11. doi: 10.1002/cncr.26028. Epub 2011 Mar 8.
3
Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.亚甲基四氢叶酸还原酶(MTHFR)基因 C677T、A1298C 和 G1793A 多态性:与男性透明细胞肾细胞癌风险和肿瘤行为的关联。
Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81. doi: 10.1016/j.clon.2011.03.005. Epub 2011 Apr 13.
4
Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.胰岛素样生长因子结合蛋白 3(IGFBP-3)基因变异与肾细胞癌有关。
BJU Int. 2011 Sep;108(5):762-70. doi: 10.1111/j.1464-410X.2010.10017.x. Epub 2011 Feb 14.
5
Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients.亚甲基四氢叶酸还原酶基因型和单倍型与日本患者肾透明细胞癌侵袭性和预后的性别特异性关联。
BJU Int. 2010 Aug;106(3):424-30. doi: 10.1111/j.1464-410X.2009.09107.x. Epub 2009 Dec 22.
6
High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.细胞质中 p27(Kip1) 的高表达与肾透明细胞癌患者的癌症特异性生存预后较差相关。
BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x. Epub 2011 Oct 7.
7
PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.纤溶酶原激活物抑制因子-1 在肾透明细胞癌中的表达及其启动子 4G/5G 多态性的调控。
J Clin Pathol. 2011 Oct;64(10):893-7. doi: 10.1136/jclinpath-2011-200182. Epub 2011 Jul 1.
8
The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.bcl2 - 938CC基因型在肾癌中预后较差且生存率较低。
J Urol. 2009 Aug;182(2):721-7. doi: 10.1016/j.juro.2009.03.081. Epub 2009 Jun 18.
9
CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.CTLA-4和CD28基因多态性与波兰人群肾细胞癌易感性的前瞻性研究
Tissue Antigens. 2015 Nov;86(5):353-61. doi: 10.1111/tan.12671. Epub 2015 Sep 25.
10
VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.VEGF 多态性与肾细胞癌发病风险增加相关。
J Urol. 2010 Oct;184(4):1273-8. doi: 10.1016/j.juro.2010.06.009. Epub 2010 Aug 17.

引用本文的文献

1
Zinner syndrome: report of a case and whole exome sequencing.津纳综合征:一例报告及全外显子测序
Basic Clin Androl. 2025 Mar 11;35(1):10. doi: 10.1186/s12610-025-00256-3.
2
Comprehensive circular RNA profiling in various sheep tissues.在各种绵羊组织中进行全面的环状 RNA 分析。
Sci Rep. 2024 Oct 31;14(1):26238. doi: 10.1038/s41598-024-76940-7.
3
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.晚期肾细胞癌的基因组和转录组图谱为个体化治疗策略提供指导。
Sci Rep. 2023 Jul 3;13(1):10720. doi: 10.1038/s41598-023-37764-z.
4
Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?经典蛋白酪氨酸磷酸酶基因的可遗传变异:它们会被证明是无辜的还是有罪的?
Front Cell Dev Biol. 2023 Jan 23;10:1051311. doi: 10.3389/fcell.2022.1051311. eCollection 2022.
5
PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.PTPRD:对大脑表型具有多效性贡献的神经生物学、遗传学和初步药理学研究
Ann N Y Acad Sci. 2019 Sep;1451(1):112-129. doi: 10.1111/nyas.14002. Epub 2019 Jan 15.
6
Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.蛋白酪氨酸磷酸酶受体δ型作为一种负调控因子抑制乳腺癌。
Oncotarget. 2017 Oct 24;8(58):98798-98811. doi: 10.18632/oncotarget.22000. eCollection 2017 Nov 17.
7
CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.CD146启动子多态性(rs3923594)与中国人群透明细胞肾细胞癌复发相关。
Dis Markers. 2017;2017:2543059. doi: 10.1155/2017/2543059. Epub 2017 May 24.
8
Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis.蛋白质酪氨酸信号转导及其在肿瘤发生中的潜在治疗意义。
Curr Pharm Des. 2017 Nov 16;23(29):4226-4246. doi: 10.2174/1381612823666170616082125.
9
Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma.基于风险相关单核苷酸多态性(SNP)的遗传评分能够揭示肾细胞癌的遗传风险。
Oncotarget. 2016 Apr 5;7(14):18631-7. doi: 10.18632/oncotarget.7623.
10
A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression.一种基因多态性影响肾细胞癌的风险和预后:与卵泡抑素样蛋白1表达的关联。
Sci Rep. 2016 May 26;6:26689. doi: 10.1038/srep26689.